Since the medium and long term objective of Caleb Multilab Inc.
is the development of incrementally modified drugs (IMD) and biogeneric medicines", a research unit was established in November 2007. They are focusing on developing incrementally modified drugs, natural products, biosimilars and drug delivery system (DDS) of proteins.
For our missions, we pursue technical co-operations and joint research with domestic & foreign pharmaceuticals and research institutes. We also participate in government grants with those research projects. We have granted 6 patents about hair-loss preventing, osteoarthritis and rheumatoid arthritis natural medicines. Based on the achievements, we continue to develop the various products and to find business partners for further steps.